This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine’s Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
MBA Chairman urges closer collaboration between banks, telecoms, and law enforcement
Kenneth Farrugia noted the shift to digital banking and rising sophistication of fraudsters.
Former Arts Council Chairman: €4.5 million invested in ‘Malta’s cultural footprint’
Albert Marshall addresses Art Council Malta’s annual report, praising the body's effort to herald local artists.
‘Protecting people is at the heart of what we do’: FIAU Director reflects on a year of enforcement, innovation, and collaboration
'At its core, the FIAU’s work is about protecting people.'
How a life-altering diagnosis reshaped one Senior Manager’s outlook
'Work will always be there, but your body carries you through it all.'
